Melariri, P., Kalombo, L., Nkuna, P., Dube, A., Hayeshi, R., Ogutu, B., . . . Swai, H. (2015). Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice. Int J Nanomedicine.
Chicago Style CitationMelariri, Paula, et al. "Oral Lipid-based Nanoformulation of Tafenoquine Enhanced Bioavailability and Blood Stage Antimalarial Efficacy and Led to a Reduction in Human Red Blood Cell Loss in Mice." Int J Nanomedicine 2015.
MLA CitationMelariri, Paula, et al. "Oral Lipid-based Nanoformulation of Tafenoquine Enhanced Bioavailability and Blood Stage Antimalarial Efficacy and Led to a Reduction in Human Red Blood Cell Loss in Mice." Int J Nanomedicine 2015.